Amputee Coalition
Providing a voice on issues affecting the limb loss community
Based in DC
🤖
AI Overview
With $1.2M in lobbying spend across 32 quarterly filings, Amputee Coalition is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
$1.2M
Total Spend
8
Years Active
1
Firms Hired
4
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $0 |
| 2020 | $150K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Insurance, Budget/Appropriations, Veterans and 1 more
- •Essential Health Benefits
- •Local Coverage Determination Clarification Act
- •Medicare O&P Improvements Act
- •BIPA 427 Regulation
- •Insurance Fairness for Amputees Act
- •Funding support for the National Limb Loss Resource Center through the Administration for Community Living
- •Funding support for limb loss registry or longitudinal database
- •Local Coverage Determination Clarification Act
- •Medicare O&P Improvements Act
- •BIPA 427 Regulation
- •State Medicaid Work Requirement Waivers
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.